各校計畫成果

活動簡介

長崎幸夫研究員積極與成大及台灣的產學研專家組成合作團隊，共同申請計畫並指導學生及年輕學者。橋接台日研究交流，已於成大及筑波大學各辦一場台日雙邊研討會，每月邀請日方學者來台，強化台灣的國際鏈結與能見度。

Dr. Nagasaki actively collaborates with experts from NCKU as well as academic, industrial, and research institutions in Taiwan to form joint research teams. He contributes to joint grant applications and mentors students and early-career researchers. In addition, Dr. Nagasaki actively promotes research exchange between Taiwan and Japan. He has organized bilateral symposia at both NCKU and the University of Tsukuba, with support from the NCKU International Research Collaboration Program and Taiwan Nanomedicine Society/Center of Applied Nanomedicine, NCKU. Furthermore, he regularly invites Japanese researchers to Taiwan, thereby strengthening international connections and enhancing global visibility.

在教育部和成大的支持下，長崎幸夫研究員不僅致力於提升學術水平和教學創新，也積極拓展國際及產業合作，以增強成大和台灣的全球影響力和聲譽。透過組成核心研究團隊，並與成大、台灣和日本的產學研專家緊密合作，長崎幸夫研究員成功實現了原計劃的所有目標，其中一些成果更是遠超預期。

1.已於 Journal of controlled release、Colloids and surfaces B-Biointerfaces 等高影響力期刊發表 5 篇論文（1 篇 top 10%；1 篇 IF >10；3 篇 IF >5）。

2.已申請 3 件專利（2 件為 PCT 專利）。

3.長崎幸夫研究員在第一年舉辦了兩場台日雙邊交流研討會，第一場在筑波大學舉辦（由成功大學國際研究合作計畫支持），另一場在成功大學舉辦（由成大醫學院奈米醫學研究中心和台灣奈米醫學會聯合主辦）。這兩場研討會將繼續舉辦，以深化台日雙方的長期研究合作。下一年度，第一場研討會將在成大舉辦（由長崎博士擔任 PI 的新一期成功大學國際研究合作計畫支持），第二場研討會將由我們的日本合作夥伴在日本舉辦。

4. 除了台日雙邊交流研討會，長崎幸夫研究員已邀請日本研究人員至成大進行交流訪問 8 次（每次都包含演講以及合作會議），其中包括東京大學理學院院長 Prof. Shin-ichi Ohkoshi 和日本高分子學會前會長 Prof. Kazunari Akiyoshi 等重量級學者。為了發揮最大的綜效，長崎幸夫研究員每次都會邀請成功大學相關研究單位共同主辦這些活動，包括臨床醫學研究所、臨床醫學研究中心、口腔醫學研究所、牙醫系和化工系，並透過成大的官方公告系統積極鼓勵其他單位的老師和學生共同參與。

5.在這一年中長崎幸夫研究員已榮獲三個日本重要科學社群頒發的獎項，包括 the Japan Society for Oxidative Stress Research、the Society of Polymer Science, Japan 和 the Japanese Society for Biomaterials。這些榮譽進一步提升了成大和台灣的國際能見度以及研究聲譽。

6.為實現上述目標，長崎幸夫研究員不僅在日本保持著活躍的研究活動（他在日本仍擔任 1 件計畫的 PI 和 6 件計畫的 co-PI），還與成大和台灣其他的產學研機構的專家合作，建立了 15 個合作團隊（共有 47 名合作研究人員），並已共同申請了 4 項國科會計畫（他曾擔任其中 2 件的 PI 和另 2 件的 co-PI；其中 3 件為整合型計畫）。此外，他還參與了 2 件成功大學國際研究合作計畫（於這兩件計畫中分別擔任 PI 和 co-PI）。

此外，長崎幸夫研究員也致力於為成大的教學以及技術轉譯做出貢獻。他不僅參與授課，也擔任碩士和博士研究生的論文委員會成員。此外，他還將擔任博士生的共同指導教授。

With support from the Ministry of Education (MOE) and National Cheng Kung University (NCKU), Dr. Nagasaki has contributed devoted himself not only to advancing academic excellence and teaching innovation, as well as but also to strengtheningextending international and industry collaborations to enhance the global visibility influence and reputation of NCKU and Taiwan. By establishing a core research team and closely collaborating with experts from NCKU as well as other industry-academia-research institutions in Taiwan and Japan, Dr. Nagasaki has successfully achieved all the major goals outlined in the original plan, withand several outcomesaccomplishments have significantly exceedinged expectations.

1. 5 papers have been published in high-impact journals including Journal of Controlled Release andColloids and Surfaces B: Biointerfaces (1 of them is in the top 10%; 1 with IF >10; 3 with them IF >5).
2. 3 patents have been submitted (2 of them are PCT applications).
3. Dr. Nagasaki has organised 2 Taiwan–Japan bilateral exchange symposiums in the first year. One of which 1 was held at the University of Tsukuba (supported by the NCKU International Research Collaboration Program), and the other one was held at NCKU (co-hosted by NCKU_CAN and Taiwan Nanomedicine Society, TNS).
   Both of these symposiums will be continued to support firmly build up long-term collaborations. , Twhich the former 1st onesumposium will be held at NCKU (supported by the newly funded NCKU International Research Collaboration Program, forof which Dr. Nagasaki serve asis the PI) and latter symposiumthe 2nd one will be held in Japan by our Japan partners next year.
4. A total 8 international exchange visits (including seminars and collaboration meetings for all these visits) have been conducted, involvingcluding distinguished researchers such as the impactful visitor like Prof. Shin-ichi Ohkoshi (Dean of the School of Science, University of Tokyo) and Prof. Kazunari Akiyoshi (former President of The Society of Polymer Science, Japan). To maximize academic the impact, Dr. Nagasaki invited researchers from multiple institutes at NCKU-including the Institute of Clinical Medicine, Center for Clinical Medicine Research, Institute of Oral Medicine, School of Dentistry, and Department of Chemical Engineering- to co-host these events and actively encouraged broad participation through the university’s official announcement system.
5. Dr. Nagasaki has received three major awards from leading Japanese scientific societies, including the Japan Society for Oxidative Stress Research, the Society of Polymer Science, Japan, and the Japanese Society for Biomaterials. These recognitions have further elevated the international reputation of NCKU and Taiwan.
6. To achieve these outcomes, Dr. Nagasaki hasnot only maintaineds strong research activity in Japan (he servinged as PI for 1 grant and co-PI for 6 grants funded in Japan). In addition, he has also teamed upestablished with scientists in NCKU and other institutes in Taiwan that 15 collaborativeon research teams had been established (involvingwith 47 collaborating investigators) with researchers at NCKU and other institutions in Taiwan. and Furthermore, 4 NSTC grants had been submitted (2he served as PI and 2 asfor 2 of them and co-PI for 2 of them; 3 of whichthem are integrated research projects), along with in addition the 2 funded NCKU International Research Collaboration Programs funded (he servinges as PI and co-PI, respectively).

Additionally, Dr. Nagasaki has is also devoted to contributeding to teaching at NCKU and toas well as advancing the translation of novel technologies. He hasnot only participatjoined in the lecture coursesteaching but also and served as a thesis committee member of master’s and Ph.D. students. Besides, hHe willis also serve asgoing to be a co-advisor of a Ph.D. student.